alymsys

Generic: bevacizumab-maly

Labeler: amneal pharmaceuticals llc
NDC Directory HUMAN PRESCRIPTION DRUG BLA Inactive Finished

Drug Facts

Product Profile

Brand Name alymsys
Generic Name bevacizumab-maly
Labeler amneal pharmaceuticals llc
Dosage Form INJECTION, SOLUTION
Routes
INTRAVENOUS
Active Ingredients

bevacizumab 400 mg/16mL

Manufacturer
Amneal Pharmaceuticals LLC

Identifiers & Regulatory

Product NDC 70121-1755
Product ID 70121-1755_0017a82d-4f35-4d17-ab5c-4744dc0effdd
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category BLA
Application Number BLA761231
Listing Expiration 2026-12-31
Marketing Start 2022-04-15

Pharmacologic Class

Established (EPC)
vascular endothelial growth factor inhibitor [epc]
Mechanism of Action
vascular endothelial growth factor-directed antibody interactions [moa] vascular endothelial growth factor inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 701211755
Hyphenated Format 70121-1755

Supplemental Identifiers

RxCUI
2599043 2599049 2599051 2599052
UPC
0370121175513 0370121175414
UNII
2S9ZZM9Q9V
NUI
N0000193543 N0000178291 N0000193542

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name alymsys (source: ndc)
Generic Name bevacizumab-maly (source: ndc)
Application Number BLA761231 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 400 mg/16mL
source: ndc
Packaging
  • 1 VIAL in 1 CARTON (70121-1755-1) / 16 mL in 1 VIAL
source: ndc

Packages (1)

70121-1755-1 1 VIAL in 1 CARTON (70121-1755-1) / 16 mL in 1 VIAL

Ingredients (1)

bevacizumab (400 mg/16mL)

Linked Drug Pages (1)

ALYMSYS ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "0017a82d-4f35-4d17-ab5c-4744dc0effdd", "openfda": {"nui": ["N0000193543", "N0000178291", "N0000193542"], "upc": ["0370121175513", "0370121175414"], "unii": ["2S9ZZM9Q9V"], "rxcui": ["2599043", "2599049", "2599051", "2599052"], "spl_set_id": ["6b4040a2-a5c5-4ff0-ab45-935d7e49cf78"], "pharm_class_epc": ["Vascular Endothelial Growth Factor Inhibitor [EPC]"], "pharm_class_moa": ["Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]", "Vascular Endothelial Growth Factor Inhibitors [MoA]"], "manufacturer_name": ["Amneal Pharmaceuticals LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (70121-1755-1)  / 16 mL in 1 VIAL", "package_ndc": "70121-1755-1", "marketing_start_date": "20220415"}], "brand_name": "ALYMSYS", "product_id": "70121-1755_0017a82d-4f35-4d17-ab5c-4744dc0effdd", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Vascular Endothelial Growth Factor Inhibitor [EPC]", "Vascular Endothelial Growth Factor Inhibitors [MoA]", "Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]"], "product_ndc": "70121-1755", "generic_name": "bevacizumab-maly", "labeler_name": "Amneal Pharmaceuticals LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ALYMSYS", "active_ingredients": [{"name": "BEVACIZUMAB", "strength": "400 mg/16mL"}], "application_number": "BLA761231", "marketing_category": "BLA", "marketing_start_date": "20220415", "listing_expiration_date": "20261231"}